0000899243-21-004246.txt : 20210202 0000899243-21-004246.hdr.sgml : 20210202 20210202181758 ACCESSION NUMBER: 0000899243-21-004246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Katz Richard D CENTRAL INDEX KEY: 0001293577 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38268 FILM NUMBER: 21583052 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allena Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001624658 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452729920 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE NEWTON EXECUTIVE PARK STREET 2: SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 BUSINESS PHONE: 617-467-4577 MAIL ADDRESS: STREET 1: ONE NEWTON EXECUTIVE PARK STREET 2: SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-01 0 0001624658 Allena Pharmaceuticals, Inc. ALNA 0001293577 Katz Richard D C/O ALLENA PHARMACEUTICALS, INC. ONE NEWTON EXECUTIVE PARK, SUITE 202 NEWTON MA 02459 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.67 2021-02-01 4 A 0 400000 0.00 A 2031-02-01 Common Stock 400000 400000 D 25% shall vest on 2/1/2022 and the remaining 75% shall vest in equal monthly installments over the following thirty-six (36) months. /s/ Kevin Brennan, attorney-in-fact 2021-02-02